Get the Stockscreener App
1.96
3.45%
-0.07
After Hours:
2.00
0.04
+2.04%
Jaguar Health Inc stock is traded at $1.96, with a volume of 98,836.
It is down -3.45% in the last 24 hours and down -16.60% over the past month.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
See More
Previous Close:
$2.03
Open:
$2
24h Volume:
98,836
Relative Volume:
0.91
Market Cap:
$4.26M
Revenue:
$10.48M
Net Income/Loss:
$-37.74M
P/E Ratio:
-0.1211
EPS:
-16.1846
Net Cash Flow:
$-29.03M
1W Performance:
+10.73%
1M Performance:
-16.60%
6M Performance:
-83.67%
1Y Performance:
-92.94%
1-Day Range:
$1.88
$2.00
1-Week Range:
$1.80
$2.16
52-Week Range:
$1.5701
$35.25
Jaguar Health Inc Stock (JAGX) Company Profile
Name
Jaguar Health Inc
Sector
Industry
Phone
415-371-8300
Address
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Compare JAGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
JAGX
Jaguar Health Inc
|
1.96 | 4.50M | 10.48M | -37.74M | -29.03M | -16.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-11-17 | Initiated | Rodman & Renshaw | Buy |
Jaguar Health Inc Stock (JAGX) Latest News
Jaguar Health Presenting at September 8-10 H.C. Wainwright Annual Global Investment Conference to Provide Updates on Near-Term Catalysts - Fall River Herald News
Jaguar Animal Health Completes Private Placement of Preferred Stock - TipRanks
Is Jaguar Health Inc. likely to announce a buybackEarnings Beat & Reliable Intraday Trade Plans - Lancaster City Council
Is Jaguar Health Inc. on track to beat earnings2025 Top Gainers & Risk Controlled Stock Alerts - Lancaster City Council
Earnings Chart Overlay Points to Jaguar Health Inc. UpsideGlobal Markets & Community Consensus Trade Signals - beatles.ru
Premarket Movers: RAPP, MCRB, JAGX. MEIP… - RTTNews
Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs - Gadsden Times
Is Jaguar Health Inc. a defensive stockJuly 2025 Technicals & Consistent Growth Stock Picks - beatles.ru
Does Jaguar Health Inc. stock benefit from AI growthJuly 2025 Drop Watch & Long-Term Growth Portfolio Plans - beatles.ru
Will Jaguar Health Inc. see short term momentumBreakout Watch & Daily Stock Trend Watchlist - Newser
Is Jaguar Health Inc. attractive for institutional investorsJuly 2025 Patterns & High Conviction Investment Ideas - خودرو بانک
What MACD and RSI say about Jaguar Health Inc.2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - Newser
Analyzing recovery setups for Jaguar Health Inc. investorsTrend Reversal & Low Volatility Stock Recommendations - Newser
Jaguar Health Inc. stock prediction for this weekPortfolio Return Report & Real-Time Market Sentiment Alerts - Newser
Using Bollinger Bands to evaluate Jaguar Health Inc.2025 Major Catalysts & Growth Oriented Trading Recommendations - Newser
Jaguar Health Presenting at September 8-10 H.C. Wainwright Annua - GuruFocus
Biotech CEO Lisa Conte of Jaguar Health to Present Company Updates at Major H.C. Wainwright Conference - Stock Titan
Should you avoid Jaguar Health Inc. stock right nowLong Setup & Comprehensive Market Scan Insights - خودرو بانک
How to recover losses in Jaguar Health Inc. stockPrice Action & Weekly Market Pulse Alerts - Newser
Can Jaguar Health Inc. hit a new high this monthRate Hike & Long-Term Safe Investment Ideas - Newser
Strategies to average down on Jaguar Health IncEarnings Trend Report & Daily Technical Forecast Reports - Newser
Will Jaguar Health Inc. rebound enough to break evenWeekly Profit Summary & Step-by-Step Swing Trade Plans - Newser
Using economic indicators to assess Jaguar Health Inc. potentialQuarterly Performance Summary & Scalable Portfolio Growth Ideas - Newser
Will Jaguar Health Inc. continue its uptrendJuly 2025 Analyst Calls & Low Risk High Reward Ideas - Newser
Comparing Jaguar Health Inc. in custom built stock radarsTrade Exit Report & Low Drawdown Momentum Trade Ideas - Newser
Intraday pattern recognizer results for Jaguar Health Inc.2025 Earnings Impact & Fast Moving Stock Watchlists - Newser
What are Jaguar Health Inc.’s recent SEC filings showingJuly 2025 Outlook & Fast Moving Stock Trade Plans - خودرو بانک
Volatility clustering patterns for Jaguar Health Inc.2025 Sector Review & Daily Chart Pattern Signal Reports - Newser
Published on: 2025-09-04 06:04:28 - Newser
Candlestick signals on Jaguar Health Inc. stock todayEarnings Overview Summary & Daily Profit Maximizing Tips - Newser
Volume spikes in Jaguar Health Inc. stock – what they meanJuly 2025 Technicals & Fast Exit Strategy with Risk Control - Newser
Statistical indicators supporting Jaguar Health Inc.’s strengthQuarterly Earnings Summary & Free Accurate Trade Setup Notifications - Newser
ETF Watch: Should you avoid Jaguar Health Inc. stock right nowGlobal Markets & Safe Entry Zone Identification - خودرو بانک
Visualizing Jaguar Health Inc. stock with heatmapsEarnings Trend Report & Weekly Stock Breakout Alerts - Newser
Using RSI to spot recovery in Jaguar Health Inc.July 2025 PreEarnings & AI Enhanced Trade Execution Alerts - Newser
Will Jaguar Health Inc. stock recover after recent drop2025 Price Momentum & High Return Stock Watch Alerts - Newser
Smart tools for monitoring Jaguar Health Inc.’s price action2025 Technical Overview & Real-Time Buy Signal Alerts - Newser
Analyzing drawdowns of Jaguar Health Inc. with statistical toolsWeekly Trend Recap & AI Driven Price Predictions - Newser
Does Jaguar Health Inc. show high probability of rebound2025 Technical Patterns & Smart Investment Allocation Tips - Newser
Jaguar Health Inc Stock (JAGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):